Documentos relacionados

1. Evaluation of T-Cell Immune Status of Reduced-Dose Cyclosporine and Everolimus Combination Therapy in Kidney Transplant Patients.
2. Análisis de impacto presupuestal de everolimus más ciclosporina y prednisona comparado con micofenolato más ciclosporina y prednisona para la profilaxis del rechazo en los receptores de trasplante de riñón en Colombia
3. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis.
4. Evaluation of factors influencing the ratio of the trough blood concentration to dose level of everolimus in Japanese kidney transplant recipients.
5. Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.
6. Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients.
7. Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study.
8. Interventions for focal segmental glomerulosclerosis in adults.
9. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
10. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.